Correlation Between Pfizer and BNY Mellon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and BNY Mellon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and BNY Mellon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and BNY Mellon International, you can compare the effects of market volatilities on Pfizer and BNY Mellon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of BNY Mellon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and BNY Mellon.

Diversification Opportunities for Pfizer and BNY Mellon

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Pfizer and BNY is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and BNY Mellon International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BNY Mellon International and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with BNY Mellon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BNY Mellon International has no effect on the direction of Pfizer i.e., Pfizer and BNY Mellon go up and down completely randomly.

Pair Corralation between Pfizer and BNY Mellon

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the BNY Mellon. In addition to that, Pfizer is 1.44 times more volatile than BNY Mellon International. It trades about -0.04 of its total potential returns per unit of risk. BNY Mellon International is currently generating about 0.15 per unit of volatility. If you would invest  7,295  in BNY Mellon International on December 26, 2024 and sell it today you would earn a total of  564.00  from holding BNY Mellon International or generate 7.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  BNY Mellon International

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
BNY Mellon International 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BNY Mellon International are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward indicators, BNY Mellon may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pfizer and BNY Mellon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and BNY Mellon

The main advantage of trading using opposite Pfizer and BNY Mellon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, BNY Mellon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BNY Mellon will offset losses from the drop in BNY Mellon's long position.
The idea behind Pfizer Inc and BNY Mellon International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes